pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-497 |
Genomic Coordinates | chr17: 7017911 - 7018022 |
Synonyms | MIRN497, hsa-mir-497, MIR497 |
Description | Homo sapiens miR-497 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-497-3p | ||||||||||||||||||||||||||||
Sequence | 64| CAAACCACACUGUGGUGUUAGA |85 | ||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | C11orf57 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | chromosome 11 open reading frame 57 | ||||||||||||||||||||
Transcript | NM_001082969 | ||||||||||||||||||||
Other Transcripts | NM_001082970 , NM_018195 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on C11orf57 | |||||||||||||||||||||
3'UTR of C11orf57 (miRNA target sites are highlighted) |
>C11orf57|NM_001082969|3'UTR 1 ATGGGAAACACTTTTGTTTTCCACATGACTGTGGATATTTACAGTTCTTACTCCTTGTGGTTTTGCCAGTGACTCTTGTT 81 CAGCACGGGGCCTGAGGTCAGAGCTGTCTTGTGCCATCTGTATGTTCTGACAGACGTCTTGTCTTCTATTTTGGCGTTAA 161 GCTTGATCCCCTTTTCTTGTTAAAAGGGAATCTGGTATTTTGTTATGAAGGTTTCTTGAAGAGATTATTTTTTTTTGCAA 241 TTAATTACGTTTAGTGTAGAGTGCATATACAGCAAATTAAAGGACCCAGAAAGCTGGATCCAATAGTGACCTGGGTACAC 321 CAATCGGAATATTGAATTTGGGGAAGTCAAGGGCTGGGATCAAGAGGTGGATTGGAACTAATGCCATGTAGGATGGTATG 401 ACAAGGCAACACTGTATTGCTCTCTGTTTATATAGCAGGTGTCACAACTAACTTGTCTTTAGCCTTGGTGCTTTGATCCT 481 TCTATATTTTGACCCCACAGGTGTGGTCCGGTTTACTTAATCAGGACATGGGCCTAAGAACAAACCTTTTCCCTTCATGA 561 TAACATCCATAGACAACTTATTAGAAGGGACTAGAGTTTTTGCAAATTTCCCTGCTGGATGGGGCCTATAGCTATACTTA 641 GTATATGCCTAAACATGGTAATTGGATAGTAAATGGTTTTCTAGTTCCATTGCTGTATATTTGCCTAAATGGACTTGTGT 721 TCAAATTATTTCTTCAATTGTCATAGATAATCCTGTACCAAATGGGGAAGAATTAGGAAATAATCATGTTGTCTAATGGT 801 ACTCTGGATTCAGGGCAGCAACTGCCATTTAAATGTTGTCTTGTTCATTTCTAAATCTGTTCATGAAGTTTAGGTTTTCC 881 CTGAAACTAAGTTGAATTATTTCCAAAATGAAACAGGCTTCTCAGGGACATATCCACTTCTTCCCAGTCTGCCTTTGGAT 961 TAAAGCACCAAGCAGAGACCACATTAATTCCCTTTGCTATACTGTGATCCTTAGTATGTTAATTCTTAAGAAACCAACAT 1041 ATCACTGAAAGAAGGCTGGCAGAACGCAAGTGCATTTTTTCACTGTGGGAAGAAAGATCAAGTGACGTATTATTTTTTCC 1121 TGGTTGTCACTTAATGGGCTGAGTAAAAAGCTTGAAAACTCAGACTTTCGGTCTTGGTTCTGCCACTCATTGGTTATGAG 1201 GAGGCCCAGAGCAGGTAAGTTCACCTTCCTGGCCTTACTTTCCTGATGTGTAATACGGAATTACTTCACAGTAGCATGAC 1281 AGTATAAGACACCAGCAGTAGATACAACTATGATGACATTCCATGAGTTGGTATTTTTAGTTCTAACTGCTAAATTTGTT 1361 CTCTTTACGGGACAGATTTCTAATAAAGTGCTTGGTCTTAAAATACATGGTTGGACAGAGGTGCCCTATCCCTTAACTAT 1441 GAGCAGGTGCTACCTTTTGGGATATTTATTTTAAATTTTAATACTTTGGTACTCAATTGTCAGTGTTCCATGGTGTGTAT 1521 TTTTATTTTTGGGATTAGTGGGGGTCTAAAGGGAGAAGAATAGTCTCTAATTACTACCTCTTAACCTAAAGCAATTATTT 1601 TGTTCCTGGAGCAAGTTAAATCTTTGTTGGAAGGAGCTTTGGCCATATATTTTTTAGCATGCATTGTTTCTGTGCCCTGA 1681 AAGTACCTGAAAGGTTTTAAGCACAGACTCAGGAAAATGTGCCAGTAGAACAGGCCATCTCCAGGAAATTGGCTCTATTT 1761 GGGTCCTGACCTTCCCTTCCTCCCAAGTTAGCAGGCTTGTTCTTTCGCAAGGAATACACATCTTGCCTTTTTTTTTTTTT 1841 TTTTGCCATGTTTTCCTTTTCTTGGTCATGTATAAGCAATAAAGCTGTTTTTTGTTCTTCATCTTTCTTAACCCCAAATT 1921 TTCTTCTATGCCTTAGGCTTCGATGGTTCTTCCAACCCCCTTAATATGGCTTAGGGTGGTTTTTCAAAACCTACAATCCC 2001 CCATTTGCACTACTGGCCATGGAACATTTATTTCTAGTGTTCCTGCCAATCAGAGATCTCTATATTAAATTCTAAAATGG 2081 GATTAAAAGAAGAGTTGGAGAATTCACACTTATTGAGTAACTGATGTCATACAACCTGGAATTTCTGAATTCCAAATAAA 2161 TAAATTTCACTCTTTGAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000532163.1 | 3UTR | UUUUUCAAAACCUACAAUCCCCCAUUUGCACUACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
95 hsa-miR-497-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT092955 | CYP2U1 | cytochrome P450 family 2 subfamily U member 1 | 2 | 4 | ||||||||
MIRT124568 | PRRC2B | proline rich coiled-coil 2B | 2 | 2 | ||||||||
MIRT125196 | EIF1AX | eukaryotic translation initiation factor 1A, X-linked | 2 | 4 | ||||||||
MIRT147296 | KPNA2 | karyopherin subunit alpha 2 | 2 | 8 | ||||||||
MIRT163999 | KIAA1109 | KIAA1109 | 2 | 4 | ||||||||
MIRT252495 | NWD1 | NACHT and WD repeat domain containing 1 | 2 | 2 | ||||||||
MIRT357969 | GRPEL2 | GrpE like 2, mitochondrial | 2 | 2 | ||||||||
MIRT443007 | TRIOBP | TRIO and F-actin binding protein | 2 | 2 | ||||||||
MIRT443524 | NETO1 | neuropilin and tolloid like 1 | 2 | 2 | ||||||||
MIRT443573 | EVX2 | even-skipped homeobox 2 | 2 | 2 | ||||||||
MIRT443656 | BACH1 | BTB domain and CNC homolog 1 | 2 | 2 | ||||||||
MIRT460670 | KRT10 | keratin 10 | 2 | 8 | ||||||||
MIRT464761 | UBE2N | ubiquitin conjugating enzyme E2 N | 2 | 2 | ||||||||
MIRT465032 | LINC00598 | long intergenic non-protein coding RNA 598 | 2 | 2 | ||||||||
MIRT465040 | TTC39C | tetratricopeptide repeat domain 39C | 2 | 2 | ||||||||
MIRT468667 | SEC62 | SEC62 homolog, preprotein translocation factor | 2 | 2 | ||||||||
MIRT473694 | MAPK8 | mitogen-activated protein kinase 8 | 2 | 4 | ||||||||
MIRT477618 | EFNA3 | ephrin A3 | 2 | 2 | ||||||||
MIRT480506 | C11orf57 | chromosome 11 open reading frame 57 | 2 | 2 | ||||||||
MIRT480592 | BUB3 | BUB3, mitotic checkpoint protein | 2 | 2 | ||||||||
MIRT486915 | ZNF398 | zinc finger protein 398 | 2 | 6 | ||||||||
MIRT487770 | ANKEF1 | ankyrin repeat and EF-hand domain containing 1 | 2 | 16 | ||||||||
MIRT493265 | MDFIC | MyoD family inhibitor domain containing | 2 | 2 | ||||||||
MIRT495271 | SLC1A2 | solute carrier family 1 member 2 | 2 | 4 | ||||||||
MIRT495309 | CHST12 | carbohydrate sulfotransferase 12 | 2 | 2 | ||||||||
MIRT496681 | DPP6 | dipeptidyl peptidase like 6 | 2 | 4 | ||||||||
MIRT496891 | FOXP1 | forkhead box P1 | 2 | 2 | ||||||||
MIRT497330 | IRF4 | interferon regulatory factor 4 | 2 | 2 | ||||||||
MIRT498272 | KIAA1644 | KIAA1644 | 2 | 2 | ||||||||
MIRT498634 | CHD4 | chromodomain helicase DNA binding protein 4 | 2 | 10 | ||||||||
MIRT500581 | USP53 | ubiquitin specific peptidase 53 | 2 | 2 | ||||||||
MIRT500751 | TMPPE | transmembrane protein with metallophosphoesterase domain | 2 | 6 | ||||||||
MIRT509668 | ZNF354B | zinc finger protein 354B | 2 | 10 | ||||||||
MIRT510919 | PSMA2 | proteasome subunit alpha 2 | 2 | 4 | ||||||||
MIRT519118 | CEP76 | centrosomal protein 76 | 2 | 2 | ||||||||
MIRT526193 | ABCG2 | ATP binding cassette subfamily G member 2 (Junior blood group) | 2 | 2 | ||||||||
MIRT526746 | HLA-DOB | major histocompatibility complex, class II, DO beta | 2 | 2 | ||||||||
MIRT527270 | FBLN2 | fibulin 2 | 2 | 2 | ||||||||
MIRT528198 | PLEKHM2 | pleckstrin homology and RUN domain containing M2 | 2 | 2 | ||||||||
MIRT528330 | TBC1D22B | TBC1 domain family member 22B | 2 | 2 | ||||||||
MIRT530346 | GABRB3 | gamma-aminobutyric acid type A receptor beta3 subunit | 2 | 2 | ||||||||
MIRT533627 | TMX3 | thioredoxin related transmembrane protein 3 | 2 | 2 | ||||||||
MIRT533738 | TMEM200C | transmembrane protein 200C | 2 | 2 | ||||||||
MIRT533779 | TMEM133 | transmembrane protein 133 | 2 | 2 | ||||||||
MIRT534317 | SKIDA1 | SKI/DACH domain containing 1 | 2 | 2 | ||||||||
MIRT538438 | COG5 | component of oligomeric golgi complex 5 | 2 | 2 | ||||||||
MIRT539156 | AREL1 | apoptosis resistant E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT539474 | ADARB2 | adenosine deaminase, RNA specific B2 (inactive) | 2 | 2 | ||||||||
MIRT539620 | SHISA9 | shisa family member 9 | 2 | 2 | ||||||||
MIRT539650 | BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | 2 | 2 | ||||||||
MIRT540346 | OPHN1 | oligophrenin 1 | 2 | 2 | ||||||||
MIRT540412 | PITPNC1 | phosphatidylinositol transfer protein, cytoplasmic 1 | 2 | 2 | ||||||||
MIRT541200 | HSP90AA1 | heat shock protein 90 alpha family class A member 1 | 2 | 2 | ||||||||
MIRT541395 | CDC27 | cell division cycle 27 | 2 | 2 | ||||||||
MIRT546443 | SNX5 | sorting nexin 5 | 2 | 2 | ||||||||
MIRT547369 | MSI2 | musashi RNA binding protein 2 | 2 | 2 | ||||||||
MIRT553288 | TSPAN3 | tetraspanin 3 | 2 | 2 | ||||||||
MIRT554402 | SERP1 | stress associated endoplasmic reticulum protein 1 | 2 | 2 | ||||||||
MIRT557822 | FOXN2 | forkhead box N2 | 2 | 2 | ||||||||
MIRT568530 | ANP32E | acidic nuclear phosphoprotein 32 family member E | 2 | 2 | ||||||||
MIRT569508 | THYN1 | thymocyte nuclear protein 1 | 2 | 2 | ||||||||
MIRT570707 | FAM69A | family with sequence similarity 69 member A | 2 | 2 | ||||||||
MIRT608376 | PIWIL2 | piwi like RNA-mediated gene silencing 2 | 2 | 2 | ||||||||
MIRT608483 | NKTR | natural killer cell triggering receptor | 2 | 6 | ||||||||
MIRT613533 | TRA2B | transformer 2 beta homolog | 2 | 2 | ||||||||
MIRT616601 | ELP2 | elongator acetyltransferase complex subunit 2 | 2 | 2 | ||||||||
MIRT618166 | DUSP18 | dual specificity phosphatase 18 | 2 | 2 | ||||||||
MIRT632059 | CEP135 | centrosomal protein 135 | 2 | 2 | ||||||||
MIRT647379 | ZDHHC23 | zinc finger DHHC-type containing 23 | 2 | 2 | ||||||||
MIRT648366 | POTED | POTE ankyrin domain family member D | 2 | 2 | ||||||||
MIRT651075 | ZNF518B | zinc finger protein 518B | 2 | 4 | ||||||||
MIRT653618 | SLC30A4 | solute carrier family 30 member 4 | 2 | 2 | ||||||||
MIRT653636 | SLC30A1 | solute carrier family 30 member 1 | 2 | 2 | ||||||||
MIRT654895 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT656232 | MFSD6 | major facilitator superfamily domain containing 6 | 2 | 2 | ||||||||
MIRT659880 | CAPRIN1 | cell cycle associated protein 1 | 2 | 2 | ||||||||
MIRT660526 | ARL4C | ADP ribosylation factor like GTPase 4C | 2 | 2 | ||||||||
MIRT666286 | SLC30A3 | solute carrier family 30 member 3 | 2 | 2 | ||||||||
MIRT686808 | SNX2 | sorting nexin 2 | 2 | 4 | ||||||||
MIRT695302 | TK1 | thymidine kinase 1 | 2 | 2 | ||||||||
MIRT699737 | SERINC3 | serine incorporator 3 | 2 | 2 | ||||||||
MIRT700794 | PIAS2 | protein inhibitor of activated STAT 2 | 2 | 2 | ||||||||
MIRT712270 | PPP1CB | protein phosphatase 1 catalytic subunit beta | 2 | 2 | ||||||||
MIRT712617 | KNSTRN | kinetochore localized astrin/SPAG5 binding protein | 2 | 2 | ||||||||
MIRT714264 | RPL10A | ribosomal protein L10a | 2 | 2 | ||||||||
MIRT715072 | TMTC1 | transmembrane and tetratricopeptide repeat containing 1 | 2 | 2 | ||||||||
MIRT715386 | TADA3 | transcriptional adaptor 3 | 2 | 2 | ||||||||
MIRT716397 | NPAS1 | neuronal PAS domain protein 1 | 2 | 2 | ||||||||
MIRT725328 | NFASC | neurofascin | 2 | 2 | ||||||||
MIRT725503 | GANAB | glucosidase II alpha subunit | 2 | 2 | ||||||||
MIRT732913 | IRAK2 | interleukin 1 receptor associated kinase 2 | 3 | 0 | ||||||||
MIRT734890 | SMAD3 | SMAD family member 3 | 3 | 0 | ||||||||
MIRT737328 | LINC02476 | long intergenic non-protein coding RNA 2476 | 3 | 0 | ||||||||
MIRT737544 | MALAT1 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | 4 | 0 | ||||||||
MIRT755545 | PAK1 | p21 (RAC1) activated kinase 1 | 3 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|